Trusted By
Price Transparency Regulations
2021-2024
Hospital Price Transparency Rules
Requires hospitals to publish pricing data and a Patient Estimate Tool.
2022-2025
Transparency in Coverage (TiC)
Requires payers to publish pricing data and a Patient Estimate Tool.
Jul 1, 2024
CY 2024 OPPS Final Rule
Requires hospitals to adopt a new standard schema, data elements, and more.
Jan 1, 2025
Drug Reporting Requirement for Hospitals
Mandates hospitals to publish detailed drug information for all drugs within the hospital’s chargemaster.
2022-2027
No Surprises Act (NSA)
Requires accurate, up-front Good Faith Estimates and Advanced EOBs.
Biotech Case Study
Drug Reimbursement Analysis
The Challenge:
When a clinical-stage Biotech company wants to understand the reimbursement landscape of their key assets pre-commercialization, what are they to do? Use price transparency data, of course.
The Solution:
With access to Drug Primary Rates, this Biotech company was able to conduct national reimbursement analyses across geographies and hospital accounts. Then, they identified specific accounts for reimbursement deep-dives and created hospital- and -payer specific analyses, that together, yielded insights and recommendations that directly informed their pricing strategy
Featured Content
Healthcare pricing is laughably complex.
It doesn't have to be.
